Page last updated: 2024-10-31

nafronyl and Hearing Loss, Sensorineural

nafronyl has been researched along with Hearing Loss, Sensorineural in 5 studies

Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.

Hearing Loss, Sensorineural: Hearing loss resulting from damage to the COCHLEA and the sensorineural elements which lie internally beyond the oval and round windows. These elements include the AUDITORY NERVE and its connections in the BRAINSTEM.

Research Excerpts

ExcerptRelevanceReference
"In the treatment of patients with sudden deafness, we found no significant difference between an oral calcium antagonist (nifedipine) and intravenous naftidrofuryl given concomitantly with vitamin A, vitamin E, and zinc."2.66Calcium antagonists in the treatment of sudden deafness. ( Beck, C; Mann, W, 1986)
" Meta-analysis was neither possible nor considered appropriate due to the differences in the type of vasodilators used, dosage and duration of treatment."2.45Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss. ( Agarwal, L; Pothier, DD, 2009)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agarwal, L1
Pothier, DD1
Tiong, TS1
Desloovere, C1
Lörz, M1
Klima, A1
Mann, W1
Beck, C2

Reviews

1 review available for nafronyl and Hearing Loss, Sensorineural

ArticleYear
Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss.
    The Cochrane database of systematic reviews, 2009, Oct-07, Issue:4

    Topics: Alprostadil; Carbon Dioxide; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Nafronyl; Ox

2009

Trials

1 trial available for nafronyl and Hearing Loss, Sensorineural

ArticleYear
Calcium antagonists in the treatment of sudden deafness.
    Archives of oto-rhino-laryngology, 1986, Volume: 243, Issue:3

    Topics: Adult; Female; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Male; Middle Aged; Nafrony

1986

Other Studies

3 other studies available for nafronyl and Hearing Loss, Sensorineural

ArticleYear
Prognostic indicators of management of sudden sensorineural hearing loss in an Asian hospital.
    Singapore medical journal, 2007, Volume: 48, Issue:1

    Topics: Adolescent; Adult; Aged; Audiometry; Child; Dexamethasone; Disease Progression; Drug Therapy, Combin

2007
[Hearing loss--current data on diagnosis and therapy].
    HNO, 1994, Volume: 42, Issue:2 Suppl

    Topics: Ear, Inner; Hearing Loss, Sensorineural; Humans; Microcirculation; Nafronyl; Vasodilator Agents

1994
Sudden sensorineural hearing loss influence of hemodynamical and hemorheological factors on spontaneous recovery and therapy results.
    Acta oto-rhino-laryngologica Belgica, 1989, Volume: 43, Issue:1

    Topics: Acute Disease; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Ear, Middle; Hearing

1989